Form 8-K - Current report:
SEC Accession No. 0001193125-26-340216
Filing Date
2026-08-07
Accepted
2026-08-07 16:02:41
Documents
9
Period of Report
2026-08-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K neog-20260803.htm   iXBRL 8-K 39822
  Complete submission text file 0001193125-26-340216.txt   144336

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20260803.xsd EX-101.SCH 25023
12 EXTRACTED XBRL INSTANCE DOCUMENT neog-20260803_htm.xml XML 4730
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 261253852
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)